Advertisement
Singapore markets close in 7 hours 16 minutes

  • Straits Times Index

    3,270.84
    -29.20 (-0.88%)
     

  • Nikkei

    38,429.40
    -405.70 (-1.04%)
     

  • Hang Seng

    18,510.54
    +31.17 (+0.17%)
     

  • FTSE 100

    8,313.67
    +100.18 (+1.22%)
     

  • Bitcoin USD

    62,567.49
    -1,303.16 (-2.04%)
     

  • CMC Crypto 200

    1,297.45
    -67.68 (-4.96%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • Dow

    38,884.26
    +31.99 (+0.08%)
     

  • Nasdaq

    16,332.56
    -16.69 (-0.10%)
     

  • Gold

    2,316.80
    -7.40 (-0.32%)
     

  • Crude Oil

    78.10
    -0.28 (-0.36%)
     

  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     

  • FTSE Bursa Malaysia

    1,608.07
    +2.39 (+0.15%)
     

  • Jakarta Composite Index

    7,123.61
    -7,135.89 (-50.04%)
     

  • PSE Index

    6,618.58
    0.00 (0.00%)
     

Company News for May 13, 2020

Zacks Equity Research
·1-min read

  • Shares of Gamida Cell Ltd. GMDA surged 36.6% after the company reported positive topline data from Phase 3 clinical study of Omidubicel in patients that have high-risk hematologic malignancies.

  • Shares of NanoViricides, Inc. NNVC soared 28.3% after the nano-biopharmaceutical company developed highly effective broad-spectrum drug candidates against the novel coronavirus.

  • Shares of Chaparral Energy, Inc. CHAP rose 23.3% after the company’sQ1 earnings of $0.23 per share surpassed the Zacks Consensus Estimate of $0.11.

  • Shares of YRC Worldwide Inc. YRCW gained 14.9% after the company’s Q1 revenues of $1.15 billion surpassed the Zacks Consensus Estimate by 2.14%.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
YRC Worldwide Inc (YRCW) : Free Stock Analysis Report
 
NanoViricides Inc (NNVC) : Free Stock Analysis Report
 
Gamida Cell Ltd (GMDA) : Free Stock Analysis Report
 
Chaparral Energy Inc (CHAP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research